Unreliability of Biomarker Research in Psychiatry
Importance: Biomarker discovery is a key research area in psychiatry, with the goals of identifying susceptibility to conditions, improving diagnostic accuracy, and predicting treatment response. Most biomarkers in psychiatry fail to be externally validated. Objective: To discuss 5 key principles used in unreliable biomarker discovery and provide alternative strategies for rigorous internal validation of biomarkers that can improve rigor and replicability. Evidence Review: Six articles were reviewed for biomarker discovery in major depressive disorder and their use of the 5 principles. Findings: Well-documented unreliable practices have contributed to failed biomarker research. Modern methods are subject to the same unreliable principles. Conclusions and Relevance: Rigorous biomarker discovery is rare and remains a challenge with complex data augmentation, synthetic data, and cross-validation strategies.
Authors
- Krishnan R. Patel (ORCID: https://orcid.org/0000-0003-2120-1939)
- Frank E. Harrell (ORCID: https://orcid.org/0000-0002-8271-5493)
- Angela Lee Jefferson (ORCID: https://orcid.org/0000-0002-8245-0587)
- Simon Vandekar (ORCID: https://orcid.org/0000-0002-7457-9073)
- Panpan Zhang
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1001/jamapsychiatry.2026.3852
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00